




























































































































































































































































































































































































































Cardiovascular system Adrenal cortex 
Increase blood pressure 
Vasoconstriction 
Aldosterone 
NaCl and water retention 
Kidneys 
Lisinopril 
Mineralocorticoid  
Receptor 
Figure	1.	
Figure	1	diagrams	the	Renin-Angiotensin	system	(RAAS).	In	RAAS,	the	liver	produces	angiotensinogen	and	
kidneys	produce	the	enzyme	Renin,	which	cleaves	angiotensinogen	to	angiotensin	I.	By	the	action	of	
angiotensin	converting	enzyme	(ACE),	angiotensin	I	is	converted	to	angiotensin	II.	Lisinopril	is	an	
angiotensin	converting	enzyme	inhibitor.	Angiotensin	II	plays	multiple	roles	in	the	body.	In	the	
cardiovascular	system,	angiotensin	II	causes	vasoconstriction	leading	to	increased	blood	pressure.	In	the	
adrenal	cortex,	angiotensin	II	leads	to	the	production	of	aldosterone.	Aldosterone	is	a	mineralocorticoid	
receptor	hormone	but	it	also	causes	NaCl	and	water	retention	and	increases	blood	pressure.		
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Figure	2.	
Figure	2	shows	dot	plots	of	data	from	the	lisinopril	and	spironolactone	treatment.	Graphs	A	and	B	show	
the	percent	of	cross-sectional	area	(CSA)	heart	damage	from	the	same	set	of	mice	stained	with	
Immunoglobulin	G	(IgG)	and	Evans	Blue	Dye	(EBD)	staining.	A	shows	the	percentage	of	IgG	heart	damage	
in	C57	wild-type	controls,	and	treated	and	untreated	mdx	dystrophic	male	mice	as	quantified	from	IgG	
staining.	B	shows	the	percentage	of	heart	damage	in	C57	wild-type	controls,	and	treated	and	untreated	
mdx	dystrophic	male	mice	as	quantified	from	EBD	staining.	IgG	is	a	more	sensitive	and	accurate	marker	for	
damage	compared	to	EBD.	Graphs	C	and	D	show	only	IgG	quantified	heart	damage	from	the	mdx	mice	on	
the	LS	treatment.	C	shows	the	percent	of	CSA	of	male	mdx	mice.	The	C57	control	group	had	a	significant	
difference	of	CSA	damage	compared	to	the	untreated	group	(p	=	0.0118).	Graph	D	shows	IgG	quantified	
heart	damage	from	the	female	mdx	mice.	p	<	0.05	indicated	by	*.	
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Figure	3.		
Figure	3	shows	percent	of	cross-sectional	area	damage	quantified	by	IgG	of	male	untreated	and	treated	
mdx	mice	from	the	beta-blocker	treatment.	There	were	no	significant	differences	between	the	treated	
and	untreated	groups.	
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Figure	4.	
Figure	4	shows	composite	micrographs	of	immunofluorescence	stain	of	Evans	Blue	Dye	(EBD),	
Immunoglobulin	G	(IgG),	and	Hematoxylin	and	Eosin	(H&E).	The	top	is	of	LS	treated,	untreated,	and	
C57	mdx	hearts.	The	bottom	shows	composite	micrographs	of	immunofluorescence	stain	of	H&E	and	
IgG	of	beta	blocker	treated	and	untreated	mdx	hearts.	Due	to	IgG	being	a	more	sensitive	marker	for	
damage,	EBD	composites	and	quantifications	were	not	done	for	the	beta-blocker	mice.	Bar	=	400µm.	
